3D Printed-Matrix Assisted Chemically Modified RNAs Bone Regenerative Therapy for Trauma and Osteoporotic Patients

Fact sheet
- Programme
- Horizon 2020 & sub-programmes
- Companies
- EURICE
- Duration
- 54 months (January 2020 – June 2024)
- Project funding
- € 6,256,758.00
- Project partners
- 11
- Technology readiness level
- 4-7
- Project website
- https://www.cmrnabone.eu
About the project
The cmRNAbone project aim to create a novel bone regenerative therapeutic approach based on combination of chemically modified RNAs (cmRNAs)-vectors embedded in a 3D-printed guiding biomaterial ink tailored to patients need.